CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
Diclofenac Capsules low dose +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02424578
NCT02424578Phase 2Completed

A Phase IIA, Open-Label, Safety and Pharmacokinetic Study of Diclofenac Capsules in Pediatric Subjects 6 to <17 Years of Age With Mild to Moderate Acute Postoperative Pain Following Elective Surgery

Iroko Pharmaceuticals, LLC·interventional·Posted Apr 23, 2015·Updated Jul 13, 2017

In Brief

A Phase 2 clinical trial evaluating Diclofenac Capsules low dose and Diclofenac Capsules high dose for Pain, Postoperative. Completed, enrolled 30 participants across 5 sites.

Detailed Summary

The purposes of this study are to evaluate the safety and tolerability and to model the single-dose pharmacokinetic profile of diclofenac capsules low dose and high dose in children ages 6 to \<17 years experiencing mild to moderate acute postoperative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 23, 2015
Enrollment StartMay 1, 2015
Primary CompletionApr 1, 2016
Study CompletionApr 19, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.2 years ago

Interventions

Diclofenac Capsules low dosedrug

Diclofenac Capsules high dosedrug